Progression from hormone dependence to autonomy and angiogenesis in mouse mammary tumours
- PMID: 2425838
- PMCID: PMC2001649
- DOI: 10.1038/bjc.1986.156
Progression from hormone dependence to autonomy and angiogenesis in mouse mammary tumours
Abstract
The transplantable pregnancy-dependent mammary tumour (TPDMT-4), the related hormone-dependent (TPDMT-4EP) and autonomous (T4-0I320 and T4-0I96) subline tumours, and the mammary glands from DDD mice were compared for angiogenic activity on the rabbit cornea by tissue implantation. The TPDMT-4EP tumour was established by serially transplanting TPDMT-4 tumour fragments in oestradiol plus progesterone treated mice. The T4-0I320 and T4-0I96 tumours directly derived from the TPDMT-4 and TPDMT-4EP tumours, respectively. Angiogenic activity was graded by macroscopic and microscopic examinations into 3 classes; negative, partial and complete angiogenesis. These tumours were comparable to mammary glands in activity and induced complete angiogenesis in only 15-23% of the implants. However, when partial and complete responses were combined as positive angiogenesis, TPDMT-4, T4-0I320, TPDMT-4EP and T4-0I96 tumour implants were angiogenic in 25, 29, 42 and 54%, respectively. The T4-0I96 tumour was significantly more angiogenic than the parent tumour but this was not so for the TPDMT-4EP tumour. Spontaneous C3H mouse mammary tumours, human gliomas from nude mice, rat Walker 256 carcinomas and rabbit VX-2 tumours induced complete angiogenesis in 54, 63, 59 and 92% of the implants, respectively. The results suggest that the TPDMT-4 tumour is unique in being weakly angiogenic and able to progress toward greater autonomy with or without augmented angiogenic activity in different conditions.
Similar articles
-
Comparative studies on estrogen receptors between a pregnancy-dependent mouse mammary tumor (TPDMT-4) and related autonomous tumors.Endocrinology. 1987 Jun;120(6):2346-56. doi: 10.1210/endo-120-6-2346. Endocrinology. 1987. PMID: 3569134
-
Accelerated progression to autonomy of a pregnancy-dependent mouse mammary tumor (TPDMT-4) by hormones.Cancer Res. 1983 May;43(5):2283-9. Cancer Res. 1983. PMID: 6831452
-
Differences in metallothionein expression in transplantable mouse mammary tumor lines.Cancer Lett. 1999 Apr 26;138(1-2):167-74. doi: 10.1016/s0304-3835(99)00002-6. Cancer Lett. 1999. PMID: 10378789
-
Prostaglandins and gangliosides of tumor microenvironment: their role in angiogenesis.Acta Oncol. 1995;34(3):439-41. doi: 10.3109/02841869509094005. Acta Oncol. 1995. PMID: 7540024 Review.
-
Vascular remodelling during the normal and malignant life cycle of the mammary gland.Microsc Res Tech. 2001 Jan 15;52(2):182-9. doi: 10.1002/1097-0029(20010115)52:2<182::AID-JEMT1004>3.0.CO;2-M. Microsc Res Tech. 2001. PMID: 11169866 Review.
Cited by
-
How can grafted breast cancer models be optimized?Cancer Biol Ther. 2011 Nov 15;12(10):855-64. doi: 10.4161/cbt.12.10.18139. Epub 2011 Nov 15. Cancer Biol Ther. 2011. PMID: 22057217 Free PMC article. Review.
-
Dipalmitoylation of radicicol results in improved efficacy against tumor growth and angiogenesis in vivo.Cancer Sci. 2007 Feb;98(2):219-25. doi: 10.1111/j.1349-7006.2006.00359.x. Cancer Sci. 2007. PMID: 17233839 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials